MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
intangible assets
$750K
Proceeds from espp
purchases
$6K
Net cash provided by
investing activities
$750K
Net cash provided by
financing activities
$6K
Net decrease in cash
and cash...
-$3,983K
Canceled cashflow
$756K
Credit loss
$4,745K
Prepaid expenses and
other current assets
-$775K
Stock-based compensation
$234K
Accounts receivable and
other receivables
-$165K
Lease amortization
$122K
Depreciation
$32K
Net cash used in
operating activities
-$4,739K
Canceled cashflow
$6,073K
Change in fair value of
common stock warrant...
$2,384K
Net loss
-$2,339K
Change in fair value of
contingent consideration
-$2,000K
Unrealized gain subsequent
to receipt of above...
$1,237K
Gain on receipt of
above food...
$1,067K
Gain on sale of
intangible assets
$750K
Accounts payable and
accrued expenses
-$399K
Inventories
$308K
Operating lease payments
-$122K
Amortization of note
receivable discount
-$69K
Other current
liabilities
-$57K
Other noncurrent
assets
$50K
Amounts due to related
parties
-$30K
Back
Back
Cash Flow
source: myfinsight.com
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)